HMGB1 and neoplasm: Following sub-cutaneous injection, mice implanted with HMGB1-shRNA-transduced B16 clones exhibited significantly reduced tumour growth when compared to mice implanted with the same number of lamin-shRNA-transduced B16 clones (Fig. 4a).